366 related articles for article (PubMed ID: 29237898)
1. Optimization of b-values in diffusion-weighted imaging for esophageal cancer: Measuring the longitudinal length of gross tumor volume and evaluating chemoradiotherapeutic efficacy.
Liu G; Yang Z; Li T; Yang L; Zheng X; Cai L
J Cancer Res Ther; 2017; 13(5):748-755. PubMed ID: 29237898
[TBL] [Abstract][Full Text] [Related]
2. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
[TBL] [Abstract][Full Text] [Related]
3. Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma.
Hou DL; Shi GF; Gao XS; Asaumi J; Li XY; Liu H; Yao C; Chang JY
Radiat Oncol; 2013 Jul; 8():169. PubMed ID: 23829638
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pathologic responders to neoadjuvant chemoradiotherapy by diffusion-weighted magnetic resonance imaging in locally advanced esophageal squamous cell carcinoma: a prospective study.
Li QW; Qiu B; Wang B; Wang DL; Yin SH; Yang H; Liu JL; Fu JH; Liu MZ; Xie CM; Liu H
Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036528
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
6. Combined modalities of magnetic resonance imaging, endoscopy and computed tomography in the evaluation of tumor responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma.
Qiu B; Wang D; Yang H; Xie W; Liang Y; Cai P; Chen Z; Liu M; Fu J; Xie C; Liu H
Radiother Oncol; 2016 Nov; 121(2):239-245. PubMed ID: 27793445
[TBL] [Abstract][Full Text] [Related]
7. Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer.
Aoyagi T; Shuto K; Okazumi S; Shimada H; Kazama T; Matsubara H
Dig Surg; 2011; 28(4):252-7. PubMed ID: 21654173
[TBL] [Abstract][Full Text] [Related]
8. Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer.
Borggreve AS; Heethuis SE; Boekhoff MR; Goense L; van Rossum PSN; Brosens LAA; van Lier ALHMW; van Hillegersberg R; Lagendijk JJW; Mook S; Ruurda JP; Meijer GJ
Eur Radiol; 2020 Apr; 30(4):1896-1907. PubMed ID: 31822974
[TBL] [Abstract][Full Text] [Related]
9. The value of intravoxel incoherent motion diffusion-weighted imaging in predicting the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
Song T; Yao Q; Qu J; Zhang H; Zhao Y; Qin J; Feng W; Zhang S; Han X; Wang S; Yan X; Li H
Eur Radiol; 2021 Mar; 31(3):1391-1400. PubMed ID: 32901300
[TBL] [Abstract][Full Text] [Related]
10. Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
Ryoo I; Kim JH; Choi SH; Sohn CH; Kim SC
Magn Reson Med Sci; 2015; 14(4):337-45. PubMed ID: 26104081
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of fluorodeoxyglucose positron emission tomography/computed tomography and magnifying endoscopy with narrow band imaging in decision-making regarding the treatment strategy for esophageal squamous cell carcinoma.
Toriyama K; Tajika M; Tanaka T; Ishihara M; Hirayama Y; Onishi S; Mizuno N; Kuwahara T; Okuno N; Matsumoto S; Sasaki E; Abe T; Yatabe Y; Hara K; Matsuo K; Tamaki T; Niwa Y
World J Gastroenterol; 2019 Dec; 25(46):6767-6780. PubMed ID: 31857778
[TBL] [Abstract][Full Text] [Related]
13. Proposed revision of the 8th edition AJCC clinical staging system for esophageal squamous cell cancer treated with definitive chemo-IMRT based on CT imaging.
Chen M; Li X; Chen Y; Liu P; Chen Z; Shen M; Liu X; Lin Y; Yang R; Ni W; Zhou X; Zhang L; Tian Y; Chen J; Fu L
Radiat Oncol; 2019 Mar; 14(1):54. PubMed ID: 30922343
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate.
Maas MC; Fütterer JJ; Scheenen TW
Invest Radiol; 2013 Nov; 48(11):779-86. PubMed ID: 23907102
[TBL] [Abstract][Full Text] [Related]
15. Diagnosed chest lesion on diffusion-weighted magnetic resonance images using apparent diffusion coefficients.
Lu NH; Hung CM; Liu KY; Chen TB; Huang YH
J Xray Sci Technol; 2016; 24(1):133-43. PubMed ID: 26890904
[TBL] [Abstract][Full Text] [Related]
16. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
Kim CK; Park BK; Kim B
AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
[TBL] [Abstract][Full Text] [Related]
17. Intravoxel incoherent motion diffusion-weighted imaging of resectable oesophageal squamous cell carcinoma: association with tumour stage.
Huang YC; Chen TW; Zhang XM; Zeng NL; Li R; Tang YL; Chen F; Chen YL
Br J Radiol; 2018 Apr; 91(1084):20170421. PubMed ID: 29308923
[TBL] [Abstract][Full Text] [Related]
18. Absolute CT perfusion parameter values after the neoadjuvant chemoradiotherapy of the squamous cell esophageal carcinoma correlate with the histopathologic tumor regression grade.
Djuric-Stefanovic A; Micev M; Stojanovic-Rundic S; Pesko P; Saranovic Dj
Eur J Radiol; 2015 Dec; 84(12):2477-84. PubMed ID: 26467704
[TBL] [Abstract][Full Text] [Related]
19. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H
J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy.
Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Aoyama N; Onishi Y; Sugimura K
AJR Am J Roentgenol; 2012 Jan; 198(1):75-82. PubMed ID: 22194481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
